更新 2025.2.10 |
Tweet
![]() |
MANUAL |
TOP PAGE |
LINK |
<< |
2158 UBIC |
LIST |
2162 マニュファク |
>> |
GNI Group Ltd. (2160:TYO-JP) |
Company INFORMATION | |||
Trading Symbol | 2160 | ||
Company Name | GNI Group Ltd. | ||
Website | https://www.gnipharma.com/ | ||
Phone Number | 03-6214-3600 | ||
Location | 東京都中央区日本橋本町2-2-2 | ||
Incorporated | 2001年11月20日 | ||
Description | |||
GNI Group has identified several drug candidate compounds for the treatment of diseases that are common in Asia. The company is a drug discovery group that has several drug candidates in its pipeline and is engaged in drug discovery activities using biotechnology. The company has a number of candidate compounds in its pipeline and is active in Japan, China, and other Asian countries. Clinical trials and drug development in China by developing drugs that target common patient diseases Manufacturing and marketing, manufacturing and marketing of antibodies, and contract research related to drug discovery. | |||
Other Websites | |||
KHRI(japanese site) market.ft.com GOOGLE FINANCE STOCKOPEDIA MARKET WATCH BARRON'S CNBC REUTERS WSJ TRADING ECONOMICS |
http://kids-hero.main.jp/japan_market/code2160.html |
To the TOP |
Copyright (c) Kids-Hero Research Institute. All Rights Reserved. |